文献速递其他结缔组织病

意大利多中心大型未选择系统性硬化症队列的生存率及预后因素

Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

该研究回顾性评估了2009年1月1日后诊断并于四家意大利风湿病中心纵向随访至2020年12月31日的912例系统性硬化症患者,5年和10年总生存率分别为94.4%和89.4%,标准化死亡比为0.96(95%CI 0.81,1.13),与意大利一般人群预期相当;男性、弥漫性皮肤受累、诊断时年龄较大、肺动脉高压、间质性肺病相关肺动脉高压、合并症及糖皮质激素治疗为死亡预测因素。

要点

  • 912例意大利系统性硬化症患者5年和10年总生存率分别为94.4%和89.4%,标准化死亡比0.96(95%CI 0.81,1.13)。
  • 肺动脉高压和间质性肺病相关肺动脉高压显著降低生存(P < 0.0001)。
  • 主要死亡预测因素包括男性(HR=2.76)、弥漫性皮肤受累(HR=3.14)、诊断时年龄较大(HR=1.08)、肺动脉高压(HR=3.21)、间质性肺病相关肺动脉高压(HR=4.11)、合并症(HR=3.53)及糖皮质激素治疗(HR=2.02)。

核心结论

  • 过去十年中,系统性硬化症患者死亡率已达到与意大利一般人群预期相似的水平。
  • 男性、弥漫性皮肤受累、合并症以及伴或不伴间质性肺病的肺动脉高压是主要的不良预后因素。

研究设计与样本

  • 回顾性评估2009年1月1日后诊断并于四家意大利风湿病中心纵向随访至2020年12月31日的系统性硬化症患者。
  • 共纳入912例患者(91.6%为女性,20%为弥漫性皮肤型系统性硬化症)。
  • 采用Kaplan-Meier法描述总生存率,Cox回归模型评估10年随访死亡预测因素,并通过标准化死亡比与意大利一般人群比较。

主要发现

  • 5年和10年总生存率分别为94.4%和89.4%。
  • 标准化死亡比为0.96(95%CI 0.81,1.13),与意大利一般人群预期相当。
  • 肺动脉高压和间质性肺病相关肺动脉高压显著降低生存(P < 0.0001)。
  • 主要死亡预测因素为男性(HR=2.76)、弥漫性皮肤受累(HR=3.14)、诊断时年龄较大(HR=1.08)、肺动脉高压(HR=3.21)、间质性肺病相关肺动脉高压(HR=4.11)、合并症(HR=3.53)及糖皮质激素治疗(HR=2.02)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Survival and death prognostic factors of SSc patients varied during the past decades. We aimed to update the 5- and 10-year survival rates and identify prognostic factors in a multicentre cohort of Italian SSc patients diagnosed after 2009. MATERIAL AND METHODS: Patients who received a diagnosis of SSc after 1 January 2009 and were longitudinally followed up in four Italian rheumatologic centres were retrospectively assessed up to 31 December 2020. Overall survival of SSc patients was described using the Kaplan-Meier method. Predictors of mortality at 10-year follow-up were assessed by the Cox regression model. A comparison of our cohort with the Italian general population was performed by determining the standardized mortality ratio (SMR). RESULTS: A total of 912 patients (91.6% females, 20% dcSSc) were included. Overall survival rates at 5 and 10 years were 94.4% and 89.4%, respectively. The SMR was 0.96 (95% CI 0.81, 1.13), like that expected in the Italian general population. Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) associated with pulmonary hypertension (PH) significantly reduced survival (P < 0.0001). Main death predictors were male gender (HR = 2.76), diffuse cutaneous involvement (HR = 3.14), older age at diagnosis (HR = 1.08), PAH (HR = 3.21), ILD-associated PH (HR = 4.11), comorbidities (HR = 3.53) and glucocorticoid treatment (HR= 2.02). CONCLUSIONS: In the past decade, SSc patients have reached similar mortality of that expected in the Italian general population. Male gender, diffuse cutaneous involvement, comorbidities and PAH with or without ILD represent the main poor prognostic factors.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Cacciapaglia F, Airò P, Fornaro M, et al. Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients. Rheumatology (Oxford). 2023. PMID: 36074979. doi:10.1093/rheumatology/keac512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。